메뉴 건너뛰기




Volumn 34, Issue 4, 2016, Pages 781-787

Risks associated with permanent discontinuation of blood pressure-lowering medications in patients with type 2 diabetes

Author keywords

all cause mortality; discontinuation of medicine; macrovascular disease; microvascular disease; proportional hazards models; prospective study

Indexed keywords

HEMOGLOBIN A1C; INDAPAMIDE; PERINDOPRIL; PLACEBO; ANTIHYPERTENSIVE AGENT;

EID: 84960449714     PISSN: 02636352     EISSN: 14735598     Source Type: Journal    
DOI: 10.1097/HJH.0000000000000841     Document Type: Article
Times cited : (37)

References (28)
  • 2
    • 70350246278 scopus 로고    scopus 로고
    • Adherence to antihypertensive medications and cardiovascular morbidity among newly diagnosed hypertensive patients
    • Mazzaglia G, Ambrosioni E, Alacqua M, Filippi A, Sessa E, Immordino V, et al. Adherence to antihypertensive medications and cardiovascular morbidity among newly diagnosed hypertensive patients. Circulation 2009; 120:1598-1605.
    • (2009) Circulation , vol.120 , pp. 1598-1605
    • Mazzaglia, G.1    Ambrosioni, E.2    Alacqua, M.3    Filippi, A.4    Sessa, E.5    Immordino, V.6
  • 3
    • 28844455699 scopus 로고    scopus 로고
    • Adherence to candesartan and placebo and outcomes in chronic heart failure in the CHARM programme: Double-blind, randomised, controlled clinical trial
    • Granger BB, Swedberg K, Ekman I, Granger CB, Olofsson B, McMurray JJ, et al. Adherence to candesartan and placebo and outcomes in chronic heart failure in the CHARM programme: double-blind, randomised, controlled clinical trial. Lancet 2005; 366:2005-2011.
    • (2005) Lancet , vol.366 , pp. 2005-2011
    • Granger, B.B.1    Swedberg, K.2    Ekman, I.3    Granger, C.B.4    Olofsson, B.5    McMurray, J.J.6
  • 5
    • 0027293786 scopus 로고
    • The relationship of treatment adherence to the risk of death after myocardial infarction in women
    • Gallagher EJ, Viscoli CM, Horwitz RI. The relationship of treatment adherence to the risk of death after myocardial infarction in women. JAMA 1993; 270:742-744.
    • (1993) JAMA , vol.270 , pp. 742-744
    • Gallagher, E.J.1    Viscoli, C.M.2    Horwitz, R.I.3
  • 6
    • 84880922378 scopus 로고    scopus 로고
    • Effects of nonpersistence with medication on outcomes in high-risk patients with cardiovascular disease
    • e7
    • Böhm M, Schumacher H, Laufs U, Sleight P, Schmieder R, Unger T, et al. Effects of nonpersistence with medication on outcomes in high-risk patients with cardiovascular disease.AmHeart J 2013; 166:306-314; e7.
    • (2013) Am Heart J , vol.166 , pp. 306-314
    • Böhm, M.1    Schumacher, H.2    Laufs, U.3    Sleight, P.4    Schmieder, R.5    Unger, T.6
  • 7
    • 79951677672 scopus 로고    scopus 로고
    • Better compliance to antihypertensive medications reduces cardiovascular risk
    • Corrao G, Parodi A, Nicotra F, Zambon A, Merlino L, Cesana G, et al. Better compliance to antihypertensive medications reduces cardiovascular risk. J Hypertens 2011; 29:610-618.
    • (2011) J Hypertens , vol.29 , pp. 610-618
    • Corrao, G.1    Parodi, A.2    Nicotra, F.3    Zambon, A.4    Merlino, L.5    Cesana, G.6
  • 8
  • 9
    • 44349111871 scopus 로고    scopus 로고
    • Adherence to prescribed antihypertensive drug treatments: Longitudinal study of electronically compiled dosing histories
    • Vrijens B, Vincze G, Kristanto P, Urquhart J, Burnier M. Adherence to prescribed antihypertensive drug treatments: longitudinal study of electronically compiled dosing histories. BMJ 2008; 336:1114-1117.
    • (2008) BMJ , vol.336 , pp. 1114-1117
    • Vrijens, B.1    Vincze, G.2    Kristanto, P.3    Urquhart, J.4    Burnier, M.5
  • 10
    • 84907862963 scopus 로고    scopus 로고
    • Followup of blood-pressure lowering and glucose control in type 2 diabetes
    • Zoungas S, Chalmers J, Neal B, Billot L, Li Q, Hirakawa Y, et al. Followup of blood-pressure lowering and glucose control in type 2 diabetes. N Engl J Med 2014; 371:1392-1406.
    • (2014) N Engl J Med , vol.371 , pp. 1392-1406
    • Zoungas, S.1    Chalmers, J.2    Neal, B.3    Billot, L.4    Li, Q.5    Hirakawa, Y.6
  • 11
    • 78650414364 scopus 로고    scopus 로고
    • Persistence of mortality reduction after the end of randomized therapy in clinical trials of blood pressure-lowering medications
    • Kostis WJ, Thijs L, Richart T, Kostis JB, Staessen JA. Persistence of mortality reduction after the end of randomized therapy in clinical trials of blood pressure-lowering medications. Hypertension 2010; 56:1060-1068.
    • (2010) Hypertension , vol.56 , pp. 1060-1068
    • Kostis, W.J.1    Thijs, L.2    Richart, T.3    Kostis, J.B.4    Staessen, J.A.5
  • 12
    • 80054737396 scopus 로고    scopus 로고
    • Long-Term results from statin trials: Answers but more unresolved questions
    • De Backer GG. Long-Term results from statin trials: answers but more unresolved questions. Eur Heart J 2011; 32:2479-2480.
    • (2011) Eur Heart J , vol.32 , pp. 2479-2480
    • De Backer, G.G.1
  • 13
    • 84863399038 scopus 로고    scopus 로고
    • Effect of daily aspirin on risk of cancer metastasis: A study of incident cancers during randomised controlled trials
    • Rothwell PM, Wilson M, Price JF, Belch JF, Meade TW, Mehta Z. Effect of daily aspirin on risk of cancer metastasis: a study of incident cancers during randomised controlled trials. Lancet 2012; 379:1591-1601.
    • (2012) Lancet , vol.379 , pp. 1591-1601
    • Rothwell, P.M.1    Wilson, M.2    Price, J.F.3    Belch, J.F.4    Meade, T.W.5    Mehta, Z.6
  • 15
    • 80054782511 scopus 로고    scopus 로고
    • Drug discontinuation effects are part of the pharmacology of a drug
    • Reidenberg MM. Drug discontinuation effects are part of the pharmacology of a drug. J Pharmacol Exp Ther 2011; 339:324-328.
    • (2011) J Pharmacol Exp Ther , vol.339 , pp. 324-328
    • Reidenberg, M.M.1
  • 16
    • 46449116410 scopus 로고    scopus 로고
    • Influence of beta-blocker continuation or withdrawal on outcomes in patients hospitalized with heart failure: Findings from the OPTIMIZE-HF program
    • Fonarow GC, Abraham WT, Albert NM, Stough WG, Gheorghiade M, Greenberg BH, et al. Influence of beta-blocker continuation or withdrawal on outcomes in patients hospitalized with heart failure: findings from the OPTIMIZE-HF program. J Am Coll Cardiol 2008; 52:190-199.
    • (2008) J Am Coll Cardiol , vol.52 , pp. 190-199
    • Fonarow, G.C.1    Abraham, W.T.2    Albert, N.M.3    Stough, W.G.4    Gheorghiade, M.5    Greenberg, B.H.6
  • 17
    • 38949209538 scopus 로고    scopus 로고
    • Incidence of death and acute myocardial infarction associated with stopping clopidogrel after acute coronary syndrome
    • Ho PM, Peterson ED, Wang L, Magid DJ, Fihn SD, Larsen GC, et al. Incidence of death and acute myocardial infarction associated with stopping clopidogrel after acute coronary syndrome. JAMA 2008; 299:532-539.
    • (2008) JAMA , vol.299 , pp. 532-539
    • Ho, P.M.1    Peterson, E.D.2    Wang, L.3    Magid, D.J.4    Fihn, S.D.5    Larsen, G.C.6
  • 18
    • 79960676489 scopus 로고    scopus 로고
    • Discontinuation of low dose aspirin and risk of myocardial infarction: Casecontrol study in UK primary care
    • Rodriguez LA, Cea-Soriano L, Martin-Merino E, Johansson S. Discontinuation of low dose aspirin and risk of myocardial infarction: casecontrol study in UK primary care. BMJ 2011; 343:d4094.
    • (2011) BMJ , vol.343 , pp. d4094
    • Rodriguez, L.A.1    Cea-Soriano, L.2    Martin-Merino, E.3    Johansson, S.4
  • 19
    • 84888002406 scopus 로고    scopus 로고
    • Cessation of dual antiplatelet treatment and cardiac events after percutaneous coronary intervention (Paris): 2 year results from a prospective observational study
    • Mehran R, Baber U, Steg PG, Ariti C, Weisz G, Witzenbichler B, et al. Cessation of dual antiplatelet treatment and cardiac events after percutaneous coronary intervention (PARIS): 2 year results from a prospective observational study. Lancet 2013; 382:1714-1722.
    • (2013) Lancet , vol.382 , pp. 1714-1722
    • Mehran, R.1    Baber, U.2    Steg, P.G.3    Ariti, C.4    Weisz, G.5    Witzenbichler, B.6
  • 20
    • 23944497531 scopus 로고    scopus 로고
    • Effect of statin use within the first 24 h of admission for acute myocardial infarction on early morbidity and mortality
    • Fonarow GC, Wright RS, Spencer FA, Fredrick PD, Dong W, Every N, et al. Effect of statin use within the first 24 h of admission for acute myocardial infarction on early morbidity and mortality. Am J Cardiol 2005; 96:611-616.
    • (2005) Am J Cardiol , vol.96 , pp. 611-616
    • Fonarow, G.C.1    Wright, R.S.2    Spencer, F.A.3    Fredrick, P.D.4    Dong, W.5    Every, N.6
  • 21
    • 34548420712 scopus 로고    scopus 로고
    • Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): A randomised controlled trial
    • Patel A, MacMahon S, Chalmers J, Neal B, Woodward M, Billot L, et al. Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial. Lancet 2007; 370:829-840.
    • (2007) Lancet , vol.370 , pp. 829-840
    • Patel, A.1    MacMahon, S.2    Chalmers, J.3    Neal, B.4    Woodward, M.5    Billot, L.6
  • 23
    • 84897873247 scopus 로고    scopus 로고
    • The effect of placebo adherence on reducing cardiovascular mortality: A meta-Analysis
    • Yue Z. Cai C, Ai-Fang Y, Feng-Min T, Li C, Bin W. The effect of placebo adherence on reducing cardiovascular mortality: a meta-Analysis. Clin Res Cardiol 2014; 103:229-235.
    • (2014) Clin Res Cardiol , vol.103 , pp. 229-235
    • Yue, Z.1    Cai, C.2    Ai-Fang, Y.3    Feng-Min, T.4    Li, C.5    Bin, W.6
  • 25
    • 0030931870 scopus 로고    scopus 로고
    • Impact of medication nonadherence on coronary heart disease outcomes: A critical review
    • McDermott MM, Schmitt B, Wallner E. Impact of medication nonadherence on coronary heart disease outcomes: a critical review. Arch Intern Med 1997; 157:1921-1929.
    • (1997) Arch Intern Med , vol.157 , pp. 1921-1929
    • McDermott, M.M.1    Schmitt, B.2    Wallner, E.3
  • 27
    • 84878930059 scopus 로고    scopus 로고
    • Adherence to evidence-based therapies after acute coronary syndrome: A retrospective population-based cohort study linking hospital, outpatient, and pharmacy health information systems in Valencia, Spain
    • Sanfélix-Gimeno G, Peiró S, Ferreros I, Pérez-Vicente R, Librero J, Catalá-López F, et al. Adherence to evidence-based therapies after acute coronary syndrome: a retrospective population-based cohort study linking hospital, outpatient, and pharmacy health information systems in Valencia, Spain. J Manag Care Pharm 2013; 19:247-257.
    • (2013) J Manag Care Pharm , vol.19 , pp. 247-257
    • Sanfélix-Gimeno, G.1    Peiró, S.2    Ferreros, I.3    Pérez-Vicente, R.4    Librero, J.5    Catalá-López, F.6
  • 28
    • 33645013643 scopus 로고    scopus 로고
    • Long-Term adherence to evidence-based secondary prevention therapies in coronary artery disease
    • Newby LK, LaPointe NM, Chen AY, Kramer JM, HammillBG, DeLong ER, et al. Long-Term adherence to evidence-based secondary prevention therapies in coronary artery disease. Circulation 2006; 113:203-212.
    • (2006) Circulation , vol.113 , pp. 203-212
    • Newby, L.K.1    LaPointe, N.M.2    Chen, A.Y.3    Kramer, J.M.4    Hammill, B.G.5    DeLong, E.R.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.